Digital Intervention for Psychedelic Preparation (DIPP): Comparing Meditation and Music-Based Programs

PHASE1RecruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

March 1, 2025

Primary Completion Date

March 31, 2026

Study Completion Date

December 31, 2026

Conditions
Healthy
Interventions
DRUG

Psilocybin 25mg

Psilocybin PEX010 is an investigational drug provided in capsule form, containing a 25 mg dose of synthetic psilocybin. The product is manufactured under Good Manufacturing Practice (GMP) standards to ensure purity, potency, and consistency. Each participant will receive a single oral dose of 25 mg psilocybin in a hydroxypropyl methylcellulose (HPMC) capsule. The intervention is administered once during the study session, with the effects expected to last approximately 4 to 6 hours.

Trial Locations (1)

Unknown

RECRUITING

University College London, London

All Listed Sponsors
lead

University College, London

OTHER